嗜铬细胞瘤和副神经节瘤的核医学:在精准医学的十字路口。

IF 4.1 2区医学 Q2 ENDOCRINOLOGY & METABOLISM

Endocrine-related cancer Pub Date : 2023-02-20 Print Date: 2023-04-01 DOI:10.1530/ERC-22-0375

David Taieb, Christelle Fargette, Abhishek Jha, Karel Pacak

{"title":"嗜铬细胞瘤和副神经节瘤的核医学:在精准医学的十字路口。","authors":"David Taieb, Christelle Fargette, Abhishek Jha, Karel Pacak","doi":"10.1530/ERC-22-0375","DOIUrl":null,"url":null,"abstract":"Precision medicine (PM) aims to maximize the risk-benefit balance of medical decisions by integrating individual patient and disease characteristics. This approach is gaining increasing recognition from clinicians, healthcare systems, pharmaceutical companies, patients, and governments. Nuclear medicine plays a critical role in PM by its virtue of providing critical information at every step of disease management, digital markers, and companion diagnostics/therapeutics. It is anticipated that technological breakthroughs and new tracers will continue to position nuclear medicine among the significant players in PM.","PeriodicalId":11654,"journal":{"name":"Endocrine-related cancer","volume":"30 4","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2023-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine.\",\"authors\":\"David Taieb, Christelle Fargette, Abhishek Jha, Karel Pacak\",\"doi\":\"10.1530/ERC-22-0375\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Precision medicine (PM) aims to maximize the risk-benefit balance of medical decisions by integrating individual patient and disease characteristics. This approach is gaining increasing recognition from clinicians, healthcare systems, pharmaceutical companies, patients, and governments. Nuclear medicine plays a critical role in PM by its virtue of providing critical information at every step of disease management, digital markers, and companion diagnostics/therapeutics. It is anticipated that technological breakthroughs and new tracers will continue to position nuclear medicine among the significant players in PM.\",\"PeriodicalId\":11654,\"journal\":{\"name\":\"Endocrine-related cancer\",\"volume\":\"30 4\",\"pages\":\"\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2023-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine-related cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1530/ERC-22-0375\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/4/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine-related cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/ERC-22-0375","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/1 0:00:00","PubModel":"Print","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 1

摘要

精准医学（PM）旨在通过整合个体患者和疾病特征，最大限度地实现医疗决策的风险效益平衡。这种方法越来越受到临床医生、医疗系统、制药公司、患者和政府的认可。核医学在PM中发挥着关键作用，因为它在疾病管理、数字标记和配套诊断/治疗的每一步都提供了关键信息。预计技术突破和新的示踪剂将继续使核医学成为PM的重要参与者之一。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine.

Precision medicine (PM) aims to maximize the risk-benefit balance of medical decisions by integrating individual patient and disease characteristics. This approach is gaining increasing recognition from clinicians, healthcare systems, pharmaceutical companies, patients, and governments. Nuclear medicine plays a critical role in PM by its virtue of providing critical information at every step of disease management, digital markers, and companion diagnostics/therapeutics. It is anticipated that technological breakthroughs and new tracers will continue to position nuclear medicine among the significant players in PM.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Endocrine-related cancer 医学-内分泌学与代谢

CiteScore

7.80

自引率

2.60%

发文量

138

审稿时长

6-12 weeks

期刊介绍： Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society. Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics. Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.